Artificial Intelligence Prediction Model of Occurrence of Cerebral Vasospasms Based on Machine Learning

Abstract

Background Symptomatic cerebral vasospasms are deleterious complication of the rupture of a cerebral aneurysm and potentially lethal. The existing scales used to classify the initial presentation of a subarachnoid hemorrhage (SAH) offer a blink of the outcome and the possibility of occurrence of symptomatic cerebral vasospasms. Altogether, neither are they sufficient to predict outcome or occurrence of events reliably nor do they offer a united front. This study tests the common grading scales and factors that otherwise affect the outcome, in an artificial intelligence (AI) based algorithm to create a reliable prediction model for the occurrence of cerebral vasospasms.

Methods Applying the R environment, an easy-to-operate command line was programmed to prognosticate the occurrence of vasospasms. Eighty-seven patients with aneurysmal SAH during a 24-month period of time were included for study purposes. The holdout and cross-validation methods were used to evaluate the algorithm (65 patients constituted the validation set and 22 patients constituted the test set). The Support Vector Machines (ksvm) classification method provided a high accuracy. The medical dataset included demographic data, the Hunt and Hess scale (H&H), Fisher grade, Barrow Neurological Institute (BNI) scale, length of intervention for aneurysmal repair, etc.

Results Our prediction model based on the AI algorithm demonstrated an accuracy of 61 to 86% for the event of symptomatic vasospasms. For subgroup analysis, 28.8% (n = 13) patients in the surgical cohort developed symptomatic vasospasm. Of these, 50% (n = 7) were admitted with Fisher scale grade 4, 37.5% (n = 5) with H&H 5, and 28.5% (n = 4) with BNI 5. In the endovascular cohort, vasospasms occurred in 31.8% (n = 14) patients. Of these, 69% (n = 9) patients were admitted with Fisher grade 4, 23% (n = 3) patients with H&H 5, and 7% (n = 1) patients with BNI 5.

Conclusion From our data, we may believe that the algorithm presented can help in identifying patients with SAH who are at “high” or “low” risk of developing symptomatic vasospasms. This risk balancing might further allow the treating physician to go for an earlier intervention trying to prevent permanent sequelae. Certainly, accuracy will improve with a higher caseload and more statistical coefficients.

Keywords

artificial intelligence - machine learning - prediction model - cerebral vasospasms - subarachnoid hemorrhage

Data Sharing

All the data of the present study and the protocol are available after publication upon request from the corresponding author upon reasonable intention.

Publication History

Received: 23 April 2024

Accepted: 14 August 2024

Accepted Manuscript online:
23 August 2024

Article published online:
21 November 2024

• References

• 1 Wilson DA, Nakaji P, Abla AA. et al. A simple and quantitative method to predict symptomatic vasospasm after subarachnoid hemorrhage based on computed tomography: beyond the Fisher scale. Neurosurgery 2012; 71 (04) 869-875
• 2 Frontera JA, Claassen J, Schmidt JM. et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 2006; 59 (01) 21-27 , discussion 21–27
• 3 Lindvall P, Runnerstam M, Birgander R, Koskinen LO. The Fisher grading correlated to outcome in patients with subarachnoid haemorrhage. Br J Neurosurg 2009; 23 (02) 188-192
• 4 Haedo MG, Grille P, Burghi G, Barbato M. Correlation between tomographic scales and vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Crit Care Sci 2023; 35 (03) 311-319
• 5 Frontera JA, Fernandez A, Schmidt JM. et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?. Stroke 2009; 40 (06) 1963-1968
• 6 Suwatcharangkoon S, De Marchis GM, Witsch J. et al. Medical treatment failure for symptomatic vasospasm after subarachnoid hemorrhage threatens long-term outcome. Stroke 2019; 50 (07) 1696-1702
• 7 Vergouwen MDI, Vermeulen M, van Gijn J. et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010; 41 (10) 2391-2395
• 8 Vossen LV, Albanna W, Conzen-Dilger C. et al. Intra-arterial nimodipine for the treatment of refractory delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J NeuroIntervent Surg 2023; (e-pub ahead of print)
• 9 Santos AN, Nii-Amon-Kotei DN, Dinger TF. et al. Impact of treatment timing on the risk of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. World Neurosurg 2022; 168: e97-e109
• 10 Güresir E, Welchowski T, Lampmann T. et al. Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: the results of induced hypertension only after the IMCVS trial: a prospective cohort study. J Clin Med 2022; 11 (19) 5850
• 11 Vatter H, Güresir E, König R. et al. Invasive diagnostic and therapeutic management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage (IMCVS): a phase 2 randomized controlled trial. J Clin Med 2022; 11 (20) 6197
• 12 Maldaner N, Zeitlberger AM, Sosnova M. et al. Development of a complication- and treatment-aware prediction model for favorable functional outcome in aneurysmal subarachnoid hemorrhage based on machine learning. Neurosurgery 2021; 88 (02) E150-E157
• 13 Dengler NF, Madai VI, Unteroberdörster M. et al. Outcome prediction in aneurysmal subarachnoid hemorrhage: a comparison of machine learning methods and established clinico-radiological scores. Neurosurg Rev 2021; 44 (05) 2837-2846